{"organizations": [], "uuid": "8af53e032d81ab768450e113441e12ae0a49a3bf", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180417.html", "section_title": "Archive News &amp; Video for Tuesday, 17 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-dms-signs-via-its-dms-biotech-unit/brief-dms-signs-via-its-dms-biotech-unit-two-agreements-for-lipofilling-solutions-in-europe-idUSFWN1RU15M", "country": "US", "domain_rank": 408, "title": "BRIEF-DMS Signs Via Its DMS Biotech Unit Two Agreements For Lipofilling Solutions In Europe", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.648, "site_type": "news", "published": "2018-04-18T00:10:00.000+03:00", "replies_count": 0, "uuid": "8af53e032d81ab768450e113441e12ae0a49a3bf"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-dms-signs-via-its-dms-biotech-unit/brief-dms-signs-via-its-dms-biotech-unit-two-agreements-for-lipofilling-solutions-in-europe-idUSFWN1RU15M", "ord_in_thread": 0, "title": "BRIEF-DMS Signs Via Its DMS Biotech Unit Two Agreements For Lipofilling Solutions In Europe", "locations": [], "entities": {"persons": [], "locations": [{"name": "europe", "sentiment": "none"}, {"name": "europe", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}, {"name": "gdynia newsroom", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 17 (Reuters) - Diagnostic Medical Systems SA :\n* ANNOUNCES UPDATES ON ITS DMS BIOTECH DIVISION * SIGNATURE VIA DMS BIOTECH OF TWO NEW AGREEMENTS FOR LIPOFILLING SOLUTIONS IN EUROPE\n* FILING OF NEW PATENT FOR PRODUCTION OF ADIPOSE TISSUE CELLS\n* DMS BIOTECH SAYS HAS FINALIZED PROSPECTIVE STUDY ON EVALUATION OF STEMCISâ€™S TECHNOLOGY IN TREATMENT OF CANINE OSTEOARTHRITIS Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-04-18T00:10:00.000+03:00", "crawled": "2018-04-18T18:16:20.028+03:00", "highlightTitle": ""}